Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
934
-
Total 13F shares, excl. options
-
246M
-
Shares change
-
-2.05M
-
Total reported value, excl. options
-
$29.9B
-
Value change
-
-$274M
-
Put/Call ratio
-
1.15
-
Number of buys
-
361
-
Number of sells
-
-483
-
Price
-
$121.50
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q2 2023
1,141 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q2 2023.
Moderna, Inc. - COMMON STOCK (MRNA) has 934 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 246M shares
of 385M outstanding shares and own 64.04% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (45.7M shares), VANGUARD GROUP INC (27.5M shares), BlackRock Inc. (24.2M shares), STATE STREET CORP (14.2M shares), Flagship Pioneering Inc. (12.9M shares), COATUE MANAGEMENT LLC (6.55M shares), GEODE CAPITAL MANAGEMENT, LLC (6.3M shares), Theleme Partners LLP (6.25M shares), MORGAN STANLEY (5.82M shares), and WELLINGTON MANAGEMENT GROUP LLP (5.13M shares).
This table shows the top 934 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.